The California Institute for Regenerative Medicine (CIRM) has awarded $11.99 million to Cedars-Sinai to support a clinical trial for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
The award will fund a novel therapy that combines stem cells and gene therapy to treat this devastating neurodegenerative disorder.
ALS destroys nerve cells in the brain and spinal cord. As those cells die, patients gradually lose muscle function.
The disease causes progressive weakness, difficulty swallowing, and breathing problems. Over time, it leads to paralysis and death.
While several therapies can slow disease progression, no cure currently exists.
Advancing a New Approach to ALS
Clive Svendsen, PhD, executive director of Cedars-Sinai’s Board of Governors Regenerative Medicine Institute, will lead the clinical trial.
The study builds on earlier CIRM-funded ALS research conducted by Svendsen and his team.
Researchers hope the new approach can protect nerve cells that control movement and help preserve muscle function.
The goal is to improve both quality of life and clinical outcomes for people living with ALS.
Combining Stem Cells and Gene Therapy
The treatment uses genetically engineered stem cells that researchers transplant into the motor cortex, the brain area responsible for voluntary movement.
After transplantation, the stem cells develop into astrocytes. These support cells help maintain nerve cell health and function.
Researchers have engineered the astrocytes to produce high levels of a protective growth factor.
That growth factor may help protect upper motor neurons, which play a critical role in controlling muscle movement.
By combining cell therapy with gene therapy, researchers aim to slow nerve cell loss and preserve function for as long as possible.
Building on Earlier CIRM-Funded Research
The trial reflects CIRM’s long-term commitment to advancing promising therapies from the laboratory into clinical testing.
“This clinical trial builds on Dr. Svendsen’s work previously funded by CIRM,” said Dr. Maria T. Millan, CIRM’s President and CEO.
“ALS is a devastating disease that attacks the spinal cord and brain and results in the progressive loss of the ability to move, swallow, and eventually breathe,” she said.
Dr. Millan also noted that Proposition 14 made the trial possible, which California voters approved in 2020. The measure reauthorized CIRM and expanded its ability to support stem cell and regenerative medicine research.
For patients living with ALS, new treatment options remain urgently needed. This trial represents another important step toward developing therapies that may slow disease progression and improve patients’ lives.

Does this mean that you can use this therapy (ALS) for cerebral palsy also?
Hi Susan, we don’t even now if it will work for ALS. If it does then it’s possible it could also be tested for CP but that would be many years away.
Can someone contact me ? My husband was just diagnosed with ALS and we would like to know more about these trials.
Hi Mona, I’m so sorry to hear about your husband. I can only imagine how distressing that must be for him and you and the whole family. If you go to the website http://www.clinicaltrials.gov and search there for ALS and stem cells you will find several clinical trials already underway. When the newly approved CIRM-funded trial opens up you’ll find details there about how you can apply to have your husband be part of it. Here is one that is underway already and might be of interest to you. https://clinicaltrials.gov/ct2/show/NCT03268603
I was recently diagnosed with PLS and only the upper motor neurons are affected. Is this something I could be involved in?
Dear Randy, I’m sorry to hear about your diagnosis. If you check the website http://www.clinicaltrials.gov you will find all the clinical trials that might be appropriate for you. Good luck.
How can I be part of this trial
Hi Michael, it hasn’t started yet but if you check out the http://www.clinicaltrials.gov website and search for ALS and Clive Svendsen you will find the trial including details of how you can determine if you are eligible and then how to apply. The trial isn’t listed there just yet but check in once a week and it should be up soon.